SFA Therapeutics Email Format

Biotechnology ResearchPennsylvania, United States2-10 Employees

SFA Therapeutics is a clinical-stage biotechnology company focused on immunomodulation to treat inflammatory and autoimmune diseases. Its platform leverages native T-regulatory (Treg) cell differentiation to influence inflammatory factors, with research licensed from Temple University in Philadelphia. The company is actively advancing its approach in areas including cancer, liver conditions, and autoimmune disorders, using orally administered small-molecule biosynthetic compounds. Based in Jenkintown, Pennsylvania, the organization operates with a small team and collaborates through its proprietary platform to explore therapeutic applications for inflammatory diseases.
Recent activity includes presenting research on an oral psoriasis candidate at a major dermatology conference, reflecting ongoing development and disclosure efforts. The firm has notable leadership and advisory appointments aimed at strengthening biostatistics, medical oversight, and strategic governance as it progresses through clinical-stage work.

Sign up for free to view info

Company overview Employee directory